Abstract: A remote control manipulator system includes: a manipulator being controlled by an operator remotely to handle an object; a stereoscopic display device that displays a right-eye image and a left-eye image so as to be stereoscopically viewed; a model image generator that generates a model image being an image of an integrated three-dimensional model viewed from a viewpoint designated by the operator, the integrated three-dimensional model being a three-dimensional model obtained by integrating the manipulator model and a surrounding environment model being generated by performing image processing on the right-eye image and the left-eye image and being a three-dimensional model of the object and a surrounding environment thereof; and a model image display device that displays the model image and is configured to be able to be viewed by the operator switching between the stereoscopic display device and the model image display device through moving the head of the operator.

Abstract: A process for measuring the mercury concentration within a hydrocarbon is provided that enables the mercury concentration to be measured simply and quickly, and with good reliability and good reproducibility. A process for measuring the mercury concentration within a hydrocarbon includes the steps of placing and weighing the hydrocarbon in a sample boat 12 containing an adsorbent that contains a metal capable of forming an amalgam with mercury, and heating the hydrocarbon inside the sample boat 12 in a combustion furnace 13, together with the adsorbent, and measuring the quantity of mercury within the thus generated gas.

Abstract: A process for measuring the mercury concentration within a hydrocarbon is provided that enables the mercury concentration to be measured simply and quickly, and with good reliability and good reproducibility. A process for measuring the mercury concentration within a hydrocarbon includes the steps of placing and weighing the hydrocarbon in a sample boat 12 containing an adsorbent that contains a metal capable of forming an amalgam with mercury, and heating the hydrocarbon inside the sample boat 12 in a combustion furnace 13, together with the adsorbent, and measuring the quantity of mercury within the thus generated gas.

Abstract: A hydroxyeicosenoic acid analog represented by the following Formula (I), the bond ? represents a cis-vinylene group or an ethynylene group; Y represents CH2, O or S(O)p wherein p is 0, 1 or 2; m represents an integer of 1 to 4 inclusive; n represents an integer of 0 to 3 inclusive; the sum of m and n is an integer of 3 to 7 inclusive; R1 represents a C1-4 alkyl group or a C3-8 cycloalkyl group; R2 represents a hydrogen atom or a methyl group; R3 represents COR4, a nitrile group, a halogen atom, a tetrazole group or a thiazolidinedione group; R4 represents OR6, NHR6, N(OH)R6, NHSO2R5, glycerol or functionalized glycerols; R5 represents a C1-15 alkyl group, a C6-10 aryl group or a C7-14 aryl group substituted with alkyl groups, halogens or amino groups; R6 represents a hydrogen, a C1-10 alkyl group or a C1-10 alkyl group substituted with a hydroxyl group, or a pharmaceutically acceptable salt or hydrate thereof. The compounds of the present invention are useful as an elastase release inhibitor.

Abstract: A hydroxyfattysulfonic acid analog represented by Formula (I): wherein X is an ethylene group, a vinylene group or an ethynylene group; Y is an ethylene group, a vinylene group, an ethynylene group, OCH2 or S(O)pCH2 wherein p is 0, 1 or 2; m is an integer of 1 to 5 inclusive; n is an integer of 0 to 4 inclusive; R1 is a C1-8 alkyl group, a C3-8 cycloalkyl group, a C1-4 alkyl group substituted with a C3-8 cycloalkyl group, a C1-4 alkyl group substituted with an aryl group or a C1-4 alkyl group substituted with an aryloxy group; R2 is a hydrogen atom or a methyl group; R1 and R2 together with the carbon atom to which they are attached may form a C3-8 cycloalkyl group; R3 is a hydrogen atom or a C2-8 acyl group; R4 is OR5 or NHR6, wherein R5 is a hydrogen atom, a C1-4 alkyl group, an alkali metal, an alkaline earth metal or an ammonium group and R6 is a hydrogen atom or a C1-4 alkyl group; or a pharmaceutically acceptable salt or a hydrate thereof.

Abstract: A prostaglandin derivative represented by the formula: wherein X is a halogen atom in the &agr;- or &bgr;-position, Y is an ethylene group, a vinylene group or an ethynylene group, A is a group represented by the formula: O(CH2)n, S(O)p(CH2)n, O(CH2)qO(CH2)r, O(CH2)qS(O)p(CH2)r, S(O)p(CH2)qS(O)p(CH2)r or S(O)p(CH2)qO(CH2)r (wherein n is an integer of 1 to 5, p is 0, 1 or 2, q is an integer of 1 to 3, and r is 0 or 1), R1 is a C3-10 cycloalkyl group, a C1-4 alkyl-C3-10 cycloalkyl group, a C3-10 cycloalkyl-C1-4 alkyl group, a C5-10 alkyl group, a C5-10 alkenyl group, a C5-10 alkynyl group or a bridged cyclic hydrocarbon group, R2 is a hydrogen atom, a C1-10 alkyl group or a C3-10 cycloalkyl group, and m is 0, 1 or 2], a pharmaceutically acceptable salt thereof or a hydrate thereof. The present invention is to provide novel PG derivatives having an excellent PGD2-like agonistic activity and a sleep-inducing action.

Abstract: The present invention relates to a catalyst for reforming that is employed when preparing a synthetic gas by reacting hydrocarbon such as methane with a reforming agent such as water, carbon dioxide, oxygen, air or the like. The present invention further relates to a process for producing a synthetic gas employing this catalyst for reforming. By employing the catalyst for reforming that is a mixed oxide having the composition expressed by the following formula in which the M and Co are in a highly dispersed state, it is possible to suppress precipitation of carbonaceous matters (carbon) when producing the synthetic gas. aM.bCo.cMg.dCa.eO (Where, a, b, c, d, and e are molar fractions, a+b+c+d=1, 0.0001≦a≦0.10, 0.0001≦b≦0.20, 0.70≦(c+d)≦0.9998, 0<c≦0.9998, 0≦d<0.9998, e=the number of oxygen necessary to maintain an electric charge balance with metallic elements.

Abstract: A prostaglandin derivative represented by the formula: [wherein X is CH2, O or S(O)q1, Y is an ethylene group, a vinylene group, an ethynylene group, O(CH2)t1 or S(O)q2(CH2)t1, Z is an ethylene group, a vinylene group or an ethynylene group, R1 is a hydrogen atom, a C1-10 alkyl group or a C3-10 cycloalkyl group, R2 is a C1-10 alkyl group, a C2-10 alkenyl group, a C2-10 alkynyl group, a C3-10 cycloalkyl group, a C1-5 alkyl-C3-10 cycloalkyl group, a C3-10 cycloalkyl-C1-5 alkyl group, a hydroxy-C1-5 alkyl group, a halogeno-C1-5 alkyl group, a C1-5 alkoxy-C1-5 alkyl group, a C2-4 alkoxycarbonyl-C1-5 alkyl group, a carboxyl-C1-5 alkyl group, a cyano-C1-5 alkyl group, a C1-5 alkyl group substituted with a group represented by the formula: —NR7R8, an acyl group, a group represented by the formula: —(CH2)t2CH(NH2)COOR9, etc., and R3 is a hydrogen atom, a C1-10 alkyl group, etc.], a pharmaceutically acceptable salt thereof or a hydrate thereof.

Abstract: The present invention relates to a catalyst for reforming that is employed when preparing a synthetic gas by reacting hydrocarbon such as methane with a reforming agent such as water, carbon dioxide, oxygen, air or the like. The present invention further relates to a process for producing a synthetic gas employing this catalyst for reforming. By employing the catalyst for reforming that is a mixed oxide having the composition expressed by the following formula in which the M and Co are in a highly dispersed state, it is possible to suppress precipitation of carbonaceous matters (carbon) when producing the synthetic gas.

Abstract: To provide a prostaglandin derivative represented by the formula: wherein A is an ethylene group, a vinylene group, an ethynylene group, O(CH2)q or S(O)r(CH2)q, R1 is a C3-10 cycloalkyl group, a C1-4 alkyl-C3-10 cycloalkyl group, a C3-10 cycloalkyl-C1-4 alkyl group, a C1-10 alkyl group, a C1-10 alkyl group substituted with hydroxyl group(s) or C1-4 alkoxy group(s), a C2-10 alkenyl group, a C2-10 alkenyl group substituted with hydroxyl group(s) or C1-4 alkoxy group(s), a C2-10 alkynyl group, a C2-10 alkynyl group substituted with hydroxyl group(s) or C1-4 alkoxy group(s) or a bridged cyclic hydrocarbon group, R2 is a hydrogen atom, a C1-10 alkyl group or a C3-10 cycloalkyl group, m is an integer of 1 to 5, n is an integer of 1 to 4, p is 0, 1 or 2, q is an integer of 1 to 5 and r is 0, 1 or 2; a pharmaceutically acceptable salt thereof or a hydrate thereof exhibit excellent action in inhibiting the growth of vascular smooth muscle and is useful as a drug for inhibition of restenosis after per

Abstract: The present invention relates to a catalyst for reforming that is employed when preparing a synthetic gas by reacting hydrocarbon such as methane with a reforming agent such as water, carbon dioxide, oxygen, air or the like. The present invention further relates to a process for producing a synthetic gas employing this catalyst for reforming. By employing the catalyst for reforming that is a mixed oxide having the composition expressed by the following formula in which the M and Co are in a highly dispersed state, it is possible to suppress precipitation of carbonaceous matters (carbon) when producing the synthetic gas. aM.bCo.cMg.dCa.eO (Where, a, b, c, d, and e are molar fractions, a+b+c+d=1, 0.0001≦a≦0.10, 0.0001≦b≦0.20, 0.70≦(c+d)≦0.9998, 0<c≦0.9998, 0≦d<0.9998, e=the number of oxygen necessary to maintain an electric charge balance with metallic elements.